title: Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production.
abstract: BACKGROUND
  Rabbits maintained on high-cholesterol diets are known to show increased immunoreactivity for amyloid beta protein in cortex and hippocampus, an effect that is amplified by presence of copper in the drinking water. Hypercholesterolemic rabbits also develop sporadic neuroinflammatory changes. The purpose of this study was to survey microglial activation in rabbits fed cholesterol in the presence or absence of copper or other metal ions, such as zinc and aluminum.
  
  
  METHODS
  Vibratome sections of the rabbit hippocampus and overlying cerebral cortex were examined for microglial activation using histochemistry with isolectin B4 from Griffonia simplicifolia. Animals were scored as showing either focal or diffuse microglial activation with or without presence of rod cells.
  
  
  RESULTS
  Approximately one quarter of all rabbits fed high-cholesterol diets showed evidence of microglial activation, which was always present in the hippocampus and not in the cortex. Microglial activation was not correlated spatially with increased amyloid immunoreactivity or with neurodegenerative changes and was most pronounced in hypercholesterolemic animals whose drinking water had been supplemented with either copper or zinc. Controls maintained on normal chow were largely devoid of neuroinflammatory changes, but revealed minimal microglial activation in one case.
  
  
  CONCLUSIONS
  Because the increase in intraneuronal amyloid immunoreactivity that results from administration of cholesterol occurs in both cerebral cortex and hippocampus, we deduce that the microglial activation reported here, which is limited to the hippocampus, occurs independent of amyloid accumulation. Furthermore, since neuroinflammation occurred in the absence of detectable neurodegenerative changes, and was also not accompanied by increased astrogliosis, we conclude that microglial activation occurs because of metabolic or biochemical derangements that are influenced by dietary factors.
authors: Department of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, 100 Newell Drive, Gainesville FL 32611, USA. qsxue@ufl.edu
authors: Qing-Shan
authors: QS
authors: Xue
authors: D Larry
authors: DL
authors: Sparks
authors: Wolfgang J
authors: WJ
authors: Streit
mesh_terms: D016229:Amyloid beta-Peptides / Q000096:biosynthesis* / Q000502:physiology; D000818:Animals; D002791:Cholesterol, Dietary / Q000008:administration & dosage / Q000009:adverse effects; D006624:Hippocampus / Q000378:metabolism* / Q000473:pathology; D006937:Hypercholesterolemia / Q000378:metabolism* / Q000473:pathology; D008297:Male; D017628:Microglia / Q000378:metabolism* / Q000473:pathology; D011817:Rabbits; D015854:Up-Regulation / Q000502:physiology
chemical_list: D016229:Amyloid beta-Peptides; D002791:Cholesterol, Dietary
references: J Neurosci. 2005 Mar 9;25(10):2566-75
references: 15758166
references: J Nutr Health Aging. 2006 Jul-Aug;10(4):247-54
references: 16886094
references: Neurobiol Aging. 1996 Mar-Apr;17(2):291-9
references: 8744411
references: Neurosci Lett. 1995 Mar 3;187(2):142-4
references: 7783962
references: J Histochem Cytochem. 1990 Nov;38(11):1683-6
references: 2212623
references: J Neuroimmunol. 1994 May;51(2):199-208
references: 7514186
references: Free Radic Res. 2005 Apr;39(4):383-8
references: 16028363
references: Ann N Y Acad Sci. 2000 Apr;903:335-44
references: 10818523
references: J Neurocytol. 1987 Apr;16(2):249-60
references: 3625239
references: Nature. 1995 Apr 13;374(6523):647-50
references: 7715705
references: Neurobiol Aging. 2001 Nov-Dec;22(6):799-809
references: 11754986
references: Glia. 2002 Nov;40(2):260-9
references: 12379913
references: J Alzheimers Dis. 2002 Feb;4(1):1-9
references: 12214013
references: Proc Natl Acad Sci U S A. 1987 May;84(9):3033-6
references: 3033674
references: Neurobiol Aging. 2000 May-Jun;21(3):383-421
references: 10858586
references: FEBS Lett. 2005 Mar 28;579(9):1995-2000
references: 15792809
references: Glia. 2002 Nov;40(2):133-9
references: 12379901
references: J Immunol. 1996 Aug 1;157(3):1213-8
references: 8757628
references: Trends Neurosci. 2006 Sep;29(9):506-10
references: 16859761
references: J Neural Transm (Vienna). 2006 Nov;113(11):1685-95
references: 17036175
references: J Mol Med (Berl). 1997 Feb;75(2):130-8
references: 9083930
references: Exp Neurol. 1994 Mar;126(1):88-94
references: 8157129
references: J Neuroinflammation. 2004 Jul 30;1(1):14
references: 15285801
references: J Neuroinflammation. 2005 Oct 31;2:24
references: 16259628
references: Curr Alzheimer Res. 2007 Apr;4(2):165-9
references: 17430242
references: Glia. 2002 Nov;40(2):232-9
references: 12379910
references: Trends Neurosci. 1996 Aug;19(8):312-8
references: 8843599
references: Dev Dyn. 1995 Apr;202(4):325-32
references: 7626790
references: J Neurosci Res. 2004 Jul 1;77(1):1-8
references: 15197750
references: Brain Res. 1999 Jun 19;832(1-2):84-96
references: 10375654
references: J Neuropathol Exp Neurol. 1996 Oct;55(10):1083-8
references: 8858005
references: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11065-9
references: 12920183
references: J Neurosci. 1997 Apr 1;17(7):2284-94
references: 9065490